KMC Speciality net profit up 120% in Q1FY26 to ₹165.7 million
KMC Speciality Hospitals posted strong Q1FY26 standalone results with net profit surging 120% YoY to ₹165.7 million. Revenue grew 38% to ₹917.8 million, supported by a 700 bps expansion in EBITDA margins to 31%. The results were approved by the Board on August 14, 2026.

*this image is generated using AI for illustrative purposes only.
KMC Speciality Hospitals reported a sharp rise in profitability for the first quarter of FY26, with standalone net profit jumping to ₹165.7 million compared to ₹75.4 million in the same period last year. The healthcare provider also saw its top-line growth accelerate, logging revenue from operations of ₹917.8 million against ₹665.5 million year-on-year.
The company’s operational efficiency improved notably during the period. EBITDA stood at ₹284.3 million, up from ₹163.9 million previously. This expansion was accompanied by a widening of the EBITDA margin to 31%, an increase from 24% in the prior year. The Board of Directors approved the unaudited financial results on August 14, 2026, following a limited review by statutory auditors Deloitte Haskins & Sells.
Financial Performance
| Metric: | Q1FY26 | Q1FY25 | Change |
|---|---|---|---|
| Revenue from operations: | ₹917.8 million | ₹665.5 million | +38.0% |
| EBITDA: | ₹284.3 million | ₹163.9 million | +73.5% |
| EBITDA Margin: | 31% | 24% | +700 bps |
| Net Profit: | ₹165.7 million | ₹75.4 million | +120.0% |
What the Numbers Show
The divergence between revenue growth and profit growth highlights significant operating leverage. While revenue increased by approximately 38%, net profit more than doubled, rising by over 120%. This suggests that the additional revenue generated contributed disproportionately to the bottom line, likely due to fixed cost absorption or improved pricing power, as evidenced by the 700 basis point expansion in EBITDA margins.
Historical Stock Returns for KMC Speciality Hospitals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.70% | -2.03% | -2.03% | -2.03% | -2.03% | -2.03% |
Will KMC Speciality Hospitals be able to sustain the 31% EBITDA margin expansion in subsequent quarters as revenue scales further?
How does this surge in profitability impact KMC's valuation multiples compared to its listed peers in the Indian healthcare sector?
What specific operational levers or cost-saving measures drove the 700 basis point margin improvement, and are these trends repeatable?


































